Clinical Trial Update: Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This entry summarizes a Phase 1/2 clinical trial evaluating ixazomib in combination with pomalidomide, clarithromycin, and dexamethasone for multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)
• clarithromycin (clarithromycin)
• ixazomib (ixazomib)

Snippet

Sponsor: Joseph Tuscano | Conditions: Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING